ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1976

High Disease Activity Is Associated with Incident Osteoporotic Fractures Among Veterans with Rheumatoid Arthritis

Katherine Wysham1, Ted Mikuls2, Bryant England2, Dolores Shoback3, Patricia Katz4, Jose Garcia1, Brian Sauer5, Beth Wallace6, John Richards7, Paul Monach8, Grant Cannon9 and Joshua Baker10, 1VA Puget Sound/University of Washington, Seattle, WA, 2University of Nebraska Medical Center, Omaha, NE, 3San Francisco VA/University of California, San Francisco, San Francisco, CA, 4University of California, San Francisco, Novato, CA, 5University of Utah, Omaha, NE, 6Michigan Medicine, VA Ann Arbor Healthcare System Center for Clinical Management Research, Ann Arbor, MI, 7Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 8Brigham and Women's, Boston, 9Salt Lake City VA Medical Center and University of Utah, Salt Lake City, 10University of Pennsylvania, Philadelphia, PA

Meeting: ACR Convergence 2020

Keywords: Disease Activity, Fracture, osteoporosis, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Osteoporosis & Metabolic Bone Disease (1973–1977)

Session Type: Abstract Session

Session Time: 3:00PM-3:50PM

Background/Purpose: Rheumatoid arthritis (RA) is a risk factor for osteoporosis and fractures yet the disease specific contributions to osteoporotic fractures (OFX) are not well understood. Chronic inflammation stimulates bone loss leading to low bone mineral density and also has negative effects on muscle mass and function, further amplifying the risk of falls and fractures. Our goal was to study whether RA disease activity, and its subcomponents, were independently associated with incident OFX.

Methods: We used the multicenter Veterans Affairs RA (VARA) registry, including participants with at least 1 DAS28-CRP measure in the analysis. Extremity, spine, and hip OFX were identified by ICD9/10 codes from inpatient and outpatient encounters and were confirmed by chart review. Cox proportional hazard models were used to assess the association between time-variant disease activity (averaged over all prior intervals) and incident OFX controlling for baseline sex, race, high ACPA ( >60 units), rheumatic disease comorbidity index, osteoporosis status and time-variant age, BMI, smoking, prednisone use, conventional synthetic DMARDs (csDMARDs) and biologic use. Baseline osteoporosis diagnosis was defined by ICD9/10 code or prior fracture. We used DAS28-CRP in our primary analysis but also considered clinical disease activity index (CDAI) and individual RA disease activity components (Tender Joint Count (TJC), Swollen Joint Count (SJC), Patient Global Assessment (PatGA), Provider Global Assessment (PrGA), and CRP) in secondary analyses.

Results: Among 2,531 Veterans followed for 10,661 patient-years (including 25,694 unique observations), 145 incident OFX were identified at a rate of 1.4 per 100 person-years. Veterans were on average 71.2±10.5 years old, 11% were female, 79% were seropositive, and 10% had a diagnosis of osteoporosis at baseline (Table 1). High disease activity by average DAS28-CRP was associated with a significantly greater risk of incident OFX [HR 2.02 (1.22-3.33), p=0.006] (Table 2) compared to those in remission. In secondary analyses, high RA disease activity by CDAI was also associated with an increased risk of OFX [HR 3.56 (1.24-10.17), p=0.018]. All of the individual disease activity components were associated with a greater risk of OFX except TJC (Table 3). Female sex and high ACPA were significantly associated with higher and lower risks for OFX [HR 2.31 (1.44-3.71) and HR 0.69 (0.49-0.96), p< 0.05].

Conclusion: High RA disease activity is associated with twice the risk of OFX compared to those whose disease is in remission. All of the individual disease activity components were associated with a greater risk of OFX except TJC. The degree of control of RA disease activity may represent a modifiable risk factor for OFX. Studies evaluating the specific mechanisms that drive the association between RA disease activity and OFX are needed to inform interventions focused on preventing this outcome.


Disclosure: K. Wysham, None; T. Mikuls, Horizon Therapeutics, 2; B. England, None; D. Shoback, None; P. Katz, None; J. Garcia, None; B. Sauer, None; B. Wallace, None; J. Richards, None; P. Monach, None; G. Cannon, Amgen, Inc., 2, Merck, 2; J. Baker, None.

To cite this abstract in AMA style:

Wysham K, Mikuls T, England B, Shoback D, Katz P, Garcia J, Sauer B, Wallace B, Richards J, Monach P, Cannon G, Baker J. High Disease Activity Is Associated with Incident Osteoporotic Fractures Among Veterans with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/high-disease-activity-is-associated-with-incident-osteoporotic-fractures-among-veterans-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-disease-activity-is-associated-with-incident-osteoporotic-fractures-among-veterans-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology